Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis

Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis

Interferon β-1a is a widely used immunomodulation treatment for multiple sclerosis. Liver function impairment is a common side effect and usually develops in the first 6 months after interferon use. Here, we describe 2 multiple sclerosis patients who developed delayed liver function impairment 5 yea...

Full description

Bibliographic Details
Main Authors: Ming-Feng Liao, Su-Chen Yen, Chun-Yen Lin, Rong-Kuo Lyu
Format: Article
Language:English
Published: Karger Publishers 2013-07-01
Series:Case Reports in Neurology
Subjects:
Multiple sclerosis
Hepatitis
Liver function impairment
Interferon β
Azathioprine
Online Access:http://www.karger.com/Article/FullText/354042

Internet

http://www.karger.com/Article/FullText/354042

Similar Items